This compound is a nitro-substituted quinazoline derivative featuring a chloro-fluoroaniline moiety. It is primarily utilized as a pharmaceutical intermediate in the synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1449430-45-8
4-[(4-Chloro-3-fluorophenyl)amino]-6-nitroquinazolin-7-ol
pharmaceutical intermediate
N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
Pharmaceutical intermediate for drug synthesis
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine
Pharmaceutical intermediate for kinase inhibitors
6-Amino-4-[(3-chloro-4-fluorophenyl)amino]-7-quinazolinol
pharmaceutical intermediate for afatinib impurities
7-fluoro-2-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one
pharmaceutical intermediate
1-(1,1-Dimethylethyl) 2-ethyl (2S)-5-oxo-1,2-pyrrolidinedicarboxylate
Pharmaceutical intermediate for peptide synthesis
1-Boc-D-Pyroglutamic acid ethyl ester
Pharmaceutical intermediate
N-(3,4-Dichlorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
impurity reference standard for afatinib
4-(3-chloro-4-fluoroanilino)-6-nitroquinazolin-7-ol
ODEICIIOTUWISY-UHFFFAOYSA-N
C1=CC(=C(C=C1NC2=NC=NC3=CC(=C(C=C32)[N+](=O)[O-])O)Cl)F
—